The Infectious Disease Diagnostics Testing Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size for infectious disease diagnostics testing has experienced significant growth recently. The market size is projected to increase from $38.52 billion in 2024 to $42.56 billion in 2025, with a compound annual growth rate (CAGR) of 10.5%.
The Infectious Disease Diagnostics Testing market is projected to grow to $62.58 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 10.1%.
Download Your Free Sample of the 2025 Infectious Disease Diagnostics Testing Market Report and Uncover Key Trends Now!The drivers in the infectious disease diagnostics testing market are:
• Rising occurrence of disease outbreaks like SARS, Ebola, and Zika
• Growing awareness for early detection and prevention of infectious diseases
• Rise in government-funded programs for disease surveillance and prevention
• Increased global travel fostering the spread of infectious diseases
The infectious disease diagnostics testing market covered in this report is segmented –
1) By Type: Molecular Diagnostic Test, Point Of Care Tests (POCT) Infectious Disease Diagnostics Test
2) By Application: Respiratory, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Sexual Health, Tropical Diseases, Liver
3) By End-User: Diagnostic Laboratories, Hospitals And Clinics, Academic Research Institutes, Other End-Users
The trends in the infectious disease diagnostics testing market are:
• There is an upward trend towards personalized medicine and targeted therapies in infectious disease diagnostics.
• Rapid, on-site testing solutions and early detection systems are becoming increasingly popular.
• Integration of digital health solutions and advanced technologies like AI and machine learning into diagnostic platforms is on the rise.
• The market is moving towards miniaturization and portability of diagnostic devices, along with the adoption of multiplex assays for simultaneous detection.
The major players in the infectious disease diagnostics testing market are:
Some of the key players in the infectious disease diagnostics testing market include F. Hoffmann-La Roche AG
North America was the largest region in the infectious disease diagnostics testing market in 2023